People with multiple sclerosis, paraplegia and neural tube defects typicall
y have neurogenic lower urinary tract dysfunction (NLUTD). This encompasses
detrusor hyperreflexia with or without detrusor sphincter dyssynergia and
hypo- or acontractility. Their effects undermine safe, effective and contro
lled storage and voiding of urine and predispose to reflux nephropathy. The
refore, patients in these diagnostic groups with NLUTD would be expected to
have increased risk of renal failure. The aim of this study was to quantif
y this risk using the General Practice Research Database (GPRD). All patien
ts registered in the database between 1994 and 1997 and aged 10-69 were inc
luded in the study. The prevalence and incidence of renal failure and renal
replacement therapy in the general population was ascertained, as was the
prevalence of multiple sclerosis, paraplegia and neural tube defects. The p
revalence of renal failure in each of the special populations was then comp
ared with the prevalence in the unaffected general population. The age-stan
dardised prevalence of renal failure in the GPRD population aged 10-69 year
s was 14 per 10,000. The rate ratio of renal failure compared with the gene
ral population in each of the years 1994-1997 for neural tube defects range
d between males (M) 6.8-9.0 and females (F) 9.2-11.5, for paraplegia M 4.1-
9.0, F 4.0-7.0, and for multiple sclerosis M 0.4-1.3, F 0.5-2.2. As expecte
d, people with paraplegia or neural tube defects were found to have a subst
antially increased risk of renal failure compared with the general populati
on. We could not demonstrate an increased risk of renal failure in people w
ith multiple sclerosis. We believe this finding requires further study, but
may reflect a problem in the recognition of renal failure in this group of
patients. We recommend that all three patient groups should be regularly s
creened so that renal impairment may be detected prior to the development o
f renal failure. Copyright (C) 2001 S.Karger AG, Basel.